Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• CorzoCBarrientos SantillanNWestinSNRamirezPTUpdates on conservative management of endometrial cancerJ Minim Invasive Gynecol201825230831328782618
   PubMed Web of Science ®Google Scholar
• RackowBWAriciAEndometrial cancer and fertilityCurr Opin Obstet Gynecol200618324525216735822
   PubMed Web of Science ®Google Scholar
• ChenMJinYLiYBiYShanYPanLOncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancerInt J Gynaecol Obstet20161321343826493012
   PubMed Web of Science ®Google Scholar
• GundersonCCFaderANCarsonKABristowREOncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic reviewGynecol Oncol2012125247748222245711
   PubMed Web of Science ®Google Scholar
• GreenwaldZRHuangLNWissingMDFrancoELGotliebWHDoes hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?Cancer201712391545155428026855
   PubMed Web of Science ®Google Scholar
• Gynecologic Oncology Branch of the Chinese Medical AssociationGuidelines for fertility-preserving treatment of gynecological malignant tumors (Chinese)Chin J Obstet Gynecol20144243248
   Google Scholar
• ColomboNCreutzbergCAmantFESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upAnn Oncol2016271164126634381
   PubMed Web of Science ®Google Scholar
• EbinaYKatabuchiHMikamiMJapan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasmsInt J Clin Oncol201621341943427116188
   PubMed Web of Science ®Google Scholar
• RodolakisABiliatisIMoricePEuropean society of gynecological oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patientsInt J Gynecol Cancer20152571258126526186070
   PubMed Web of Science ®Google Scholar
• CasadioPGuasinaFParadisiRLeggieriCCapraraGSeracchioliRFertility-sparing treatment of endometrial cancer with initial infiltration of myometrium by resectoscopic surgery: a pilot studyOncologist201823447848029317550
   PubMed Web of Science ®Google Scholar
• KimYBHolschneiderCHGhoshKNiebergRKMontzFJProgestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literatureCancer19977923203279010105
   PubMed Web of Science ®Google Scholar
• QinYYuZYangJOral progestin treatment for early-stage endometrial cancer: a systematic review and meta-analysisInt J Gynecol Cancer20162661081109127177279
   PubMed Web of Science ®Google Scholar
• YuMCaoDYYangJXWuYMChenYLXieXMulti-center clinical study of conservative treatment with progestin in early endometrial cancer (Chinese)Abstracts of the 10th National Obstetrics and Gynecology Conference of the Chinese Medical AssociationXiamen201246
   Google Scholar
• WangYXPanLYHuangHFShenKLangJHClinical analysis of conservative treatment with progestin in young women with endometrial carcinomaChin J Cancer Prev Treat2011187541544 Chinese
   Google Scholar
• MaoYWanXChenYLvWXieXOutcomes of conservative therapy for young women with early endometrial adenocarcinomaFertil Steril201093128328519962142
   PubMed Web of Science ®Google Scholar
• ShanBERenYLSunJMXyTJiang zx, Ju XZ. A phase II study of fertility-sparing treatment with megestrol acetate for endometrial carcinoma and atypical hyperplasia in young women (Chinese)China Oncol2012226424429
   Google Scholar
• CaoDYYuMYangJXPregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestinZhonghua Fu Chan Ke Za Zhi2013487519522 Chinese24284224
   PubMedGoogle Scholar
• ShanBERenYLSunJMA prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young womenArch Gynecol Obstet201328851115112323644919
   PubMed Web of Science ®Google Scholar
• ZhouRYangYLuQPrognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patientsGynecol Oncol2015139342442826428941
   PubMed Web of Science ®Google Scholar
• LiYLTreatment of 40 cases of early endometrial carcinoma with dydrogesterone combined with hysteroscopic resection and its effect on reproductive function (Chinese)Chin Foreign Med Res2017157102103
   Google Scholar
• YuMYangJXWuMLangJHHuoZShenKFertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometriumFertil Steril20099262122212419591991
   PubMed Web of Science ®Google Scholar
• QianHChenZHClinical analysis of conservative treatment of 44 patients with early endometrial cancer (Chinese)Heilongjiang Med J201528511111113
   Google Scholar
• WangCJChaoAYangLYFertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort studyInt J Gynecol Cancer201424471872824577149
   PubMed Web of Science ®Google Scholar
• ZhangYTherapeutic effect and pregnancy analysis of progesterone-preserving fertility in young patients with endometrial cancer and dysplasia (doctoral thesis)Tianjin Medical University2017 Chinese
   Google Scholar
• YangYFLiaoYYLiuXLSuSGLiLZPengNFPrognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatmentGynecol Oncol2015139341942326494424
   PubMed Web of Science ®Google Scholar
• YuMShenKYangJXOutcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young womenChin J Obstet Gynecol2006414242245 Chinese
   Google Scholar
• KoskasMUzanJLutonDRouzierRDaraïEPrognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysisFertil Steril2014101378579424388202
   PubMed Web of Science ®Google Scholar
• ParkJYKimDYKimJHLong-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)Eur J Cancer201349486887423072814
   PubMed Web of Science ®Google Scholar
• GallosIDYapJRajkhowaMLuesleyDMCoomarasamyAGuptaJKRegression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysisAm J Obstet Gynecol20122074266 e1–1223021687
   PubMed Web of Science ®Google Scholar
• ZhouHCaoDYangJShenKLangJGonadotropin-releasing hormone agonist combined with a levonorgestrel-releasing intrauterine system or letrozole for fertility-preserving treatment of endometrial carcinoma and complex atypical hyperplasia in young womenInt J Gynecol Cancer20172761178118228562472
   PubMed Web of Science ®Google Scholar
• KimMKYoonBSParkHConservative treatment with medroxy-progesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot studyInt J Gynecol Cancer201121467367721546871
   PubMed Web of Science ®Google Scholar
• FalconeFLaurelliGLositoSdi NapoliMGranataVGreggiSFertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancerJ Gynecol Oncol2017281e227670256
   PubMed Web of Science ®Google Scholar
• GiampaolinoPdi Spiezio SardoAMolloAHysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective studyJ Minim Invasive Gynecol2018S1553S4650183034730349
   Google Scholar
• LiCMLuoYMaoQXChenJAnalysis of 8 cases with early reproductive endometrial cancer treated by hysteroscopic resection combined with progesterone (Chinese)J Prac Obste Gynecol2013293224226
   Google Scholar
• WangQGuoQGaoSFertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young womenInt J Clin Exp Med201588138041381026550329
   PubMed Web of Science ®Google Scholar
• WangFYuAXuHFertility preserved hysteroscopic approach for the treatment of stage Ia endometrioid carcinomaInt J Gynecol Cancer20172791919192528885274
   PubMed Web of Science ®Google Scholar
• CovensAThomasGShawPA phase II study of leuprolide in advanced/recurrent endometrial cancerGynecol Oncol19976411261298995560
   PubMed Web of Science ®Google Scholar
• AsburyRFBrunettoVLLeeRBReidGRoceretoTFGynecologic Oncology GroupGoserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group studyAm J Clin Oncol200225655756012477997
   PubMed Web of Science ®Google Scholar
• GallosIDShehmarMThangaratinamSPapapostolouTKCoomarasamyAGuptaJKOral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysisAm J Obstet Gynecol20102036547 e1–1020934679
   PubMed Web of Science ®Google Scholar
• YangBXieLZhangHInsulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patientsJ Gynecol Oncol2018293e3529533020
   PubMed Web of Science ®Google Scholar
• MinigLFranchiDBoveriSCasadioCBoccioloneLSideriMProgestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young womenAnn Oncol201122364364920876910
   PubMed Web of Science ®Google Scholar
• GadducciASpiritoNBaroniETanaRGenazzaniARThe fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic optionGynecol Endocrinol2009251068369119562604
   PubMed Web of Science ®Google Scholar
• ParkJYKimDYKimTJHormonal therapy for women with stage IA endometrial cancer of all gradesObstet Gynecol2013122171423743459
   PubMed Web of Science ®Google Scholar
• InoueOHamataniTSusumuNFactors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasiaReprod Biol Endocrinol201614226769300
   PubMed Web of Science ®Google Scholar
• YuMJLiuQYHysteroscopic resection combined with progesterone for the treatment of early endometrial cancer with fertility preservation in 5 casesChin J Cancer Prev Treat201623s2258259 Chinese
   Google Scholar
• DengZWZhaoYQZengXYeHQieMROutcomes and prognosis of early endometrial carcinoma in young patients with Hysteroscopy combined progesterone therapy (Chinese)J Pract Obstet Gynecol20175366369
   Google Scholar
• HuCYTianYNChLJiaLLiuTDEffect of hysteroscopic electrotomy combined with progesterone on early reproductive endometrial cancer (Chinese)Clin Med China2016324332334
   Google Scholar
• ChenRClinical analysis of 13 cases of fertility preservation of early endometrial cancerMed Innovat China20151224117119117118 Chinese
   Google Scholar
• TongXMLinXNJiangHFJiangLYZhangSYLiangFBFertility-preserving treatment and pregnancy outcomes in the early stage of endometrial carcinomaChin Med J (Engl)2013126152965297123924476
   PubMed Web of Science ®Google Scholar
• KalogeraEDowdySCBakkum-GamezJNPreserving fertility in young patients with endometrial cancer: current perspectivesInt J Womens Health2014669170125114594
   PubMedGoogle Scholar
• IchinoseMFujimotoAOsugaYThe influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasiaInt J Gynecol Cancer201323228829323314282
   PubMed Web of Science ®Google Scholar
• ChaoASChaoAWangCJLaiCHWangHSObstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature reviewTaiwan J Obstet Gynecol2011501626621482377
   PubMed Web of Science ®Google Scholar
• ColomboNCreutzbergCAmantFESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upInt J Gynecol Cancer201626123026645990
   PubMed Web of Science ®Google Scholar
• BaekJSLeeWHKangWDKimSMFertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: is it effective?Obstet Gynecol Sci2016591243126866032
   PubMedGoogle Scholar
• GotliebWHBeinerMEShalmonBOutcome of fertility-sparing treatment with progestins in young patients with endometrial cancerObstet Gynecol2003102471872514551001
   PubMed Web of Science ®Google Scholar
• RamirezPTFrumovitzMBodurkaDCSunCCLevenbackCHormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature reviewGynecol Oncol200495113313815385122
   PubMed Web of Science ®Google Scholar
• UshijimaKYahataHYoshikawaHMulticenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young womenJ Clin Oncol200725192798280317602085
   PubMed Web of Science ®Google Scholar
• PerriTKorachJGotliebWHProlonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achievedInt J Gynecol Cancer2011211727821178572
   PubMed Web of Science ®Google Scholar
• ParkJYLeeSHSeongSJProgestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestinGynecol Oncol2013129171123283299
   PubMed Web of Science ®Google Scholar
• YamagamiWSusumuNMakabeTIs repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?J Gynecol Oncol2018292e2129400014
   PubMed Web of Science ®Google Scholar
• TamauchiSKajiyamaHUtsumiFEfficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancerJ Obstet Gynaecol Res201844115115629121428
   PubMed Web of Science ®Google Scholar
• YuMYangJXCaoDYWangYShenKDiagnosis and management in patients with recurrent stage I endometrial cancer after primary fertility-preserving treatment (Chinese)J Shandong Univ20185652329
   Google Scholar
• LancasterJMPowellCBKauffNDSociety of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsGynecol Oncol2007107215916217950381
   PubMed Web of Science ®Google Scholar
• HoekstraAVKimJJKehPSchinkJCAbsence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case reportJ Reprod Med2008531186987319097521
   PubMed Web of Science ®Google Scholar
• HahnHSYoonSGHongJSConservative treatment with progestin and pregnancy outcomes in endometrial cancerInt J Gynecol Cancer20091961068107319820370
   PubMed Web of Science ®Google Scholar
• AiZYinLZhouXInhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancerCancer2006107474675616826583
   PubMed Web of Science ®Google Scholar
• ErkanliSKayaselcukFKuscuEExpression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometriumInt J Gynecol Cancer20061631412141816803539
   PubMed Web of Science ®Google Scholar
• ChenXZhangZFengYAberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistanceMod Pathol200922569970819287462
   PubMed Web of Science ®Google Scholar
• GuCZhangZYuYInhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancerCancer Sci2011102355756421205080
   PubMed Web of Science ®Google Scholar
• ZhaoSChenXLuXYuYFengYEpidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinomaGynecol Oncol20071051455417240435
   PubMed Web of Science ®Google Scholar
• ZhangZDongLSuiLMetformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expressionInt J Gynecol Cancer201121221322121270604
   PubMed Web of Science ®Google Scholar
• AiZWangJWangYLuLTongJTengYOverexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathwayCancer2010116153603361320564127
   PubMed Web of Science ®Google Scholar